Correlation Between Verve Therapeutics and Vanda Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Verve Therapeutics and Vanda Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verve Therapeutics and Vanda Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Verve Therapeutics and Vanda Pharmaceuticals, you can compare the effects of market volatilities on Verve Therapeutics and Vanda Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verve Therapeutics with a short position of Vanda Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verve Therapeutics and Vanda Pharmaceuticals.

Diversification Opportunities for Verve Therapeutics and Vanda Pharmaceuticals

0.48
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Verve and Vanda is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding Verve Therapeutics and Vanda Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vanda Pharmaceuticals and Verve Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verve Therapeutics are associated (or correlated) with Vanda Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vanda Pharmaceuticals has no effect on the direction of Verve Therapeutics i.e., Verve Therapeutics and Vanda Pharmaceuticals go up and down completely randomly.

Pair Corralation between Verve Therapeutics and Vanda Pharmaceuticals

Given the investment horizon of 90 days Verve Therapeutics is expected to under-perform the Vanda Pharmaceuticals. In addition to that, Verve Therapeutics is 2.17 times more volatile than Vanda Pharmaceuticals. It trades about 0.0 of its total potential returns per unit of risk. Vanda Pharmaceuticals is currently generating about 0.19 per unit of volatility. If you would invest  469.00  in Vanda Pharmaceuticals on August 30, 2024 and sell it today you would earn a total of  50.00  from holding Vanda Pharmaceuticals or generate 10.66% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Verve Therapeutics  vs.  Vanda Pharmaceuticals

 Performance 
       Timeline  
Verve Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Verve Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.
Vanda Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vanda Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong fundamental indicators, Vanda Pharmaceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Verve Therapeutics and Vanda Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Verve Therapeutics and Vanda Pharmaceuticals

The main advantage of trading using opposite Verve Therapeutics and Vanda Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verve Therapeutics position performs unexpectedly, Vanda Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vanda Pharmaceuticals will offset losses from the drop in Vanda Pharmaceuticals' long position.
The idea behind Verve Therapeutics and Vanda Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Complementary Tools

Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account